Sovihep V (VELPATASVIR 100 mg/SOFOSBUVIR 400 mg) x 28 Tablets

Benefits of VELPATASVIR 100 mg / SOFOSBUVIR 400 mg

• Offers high cure rates across all HCV genotypes.
• Stops the hepatitis C virus from multiplying.
• Helps reduce liver inflammation and damage.
• Lowers the risk of liver cirrhosis.
• May reduce risk of liver failure and liver cancer.
• Improves long-term liver health.
• Convenient once-daily oral tablet.
• Generally well tolerated by most patients.
• Helps prevent progression of liver disease.
• Improves quality of life after successful treatment.

How Does It Work?

Velpatasvir and Sofosbuvir are direct-acting antiviral (DAA) medicines that work together to treat hepatitis C. Velpatasvir blocks the NS5A protein, while Sofosbuvir inhibits the NS5B RNA polymerase enzyme, both essential for viral replication. Together, they stop the virus from multiplying, reduce the viral load, and help achieve a sustained virologic response (cure) in most patients.

Precautions

• Take the medicine exactly as prescribed by your doctor.
• Complete the full treatment course without skipping doses.
• Inform your doctor if you have hepatitis B, liver disease, or kidney problems.
• Regular blood tests may be required during treatment.
• Avoid alcohol to protect the liver.
• Inform your doctor about all medicines and supplements you are taking.
• Use during pregnancy or breastfeeding only if advised.
• Take the tablet at the same time daily.
• Do not stop treatment without medical advice.
• Attend follow-up visits for monitoring and confirmation of cure.

Side Effects

• Headache
• Fatigue
• Nausea
• Insomnia
• Diarrhea

Buy Sovihep V Velpatasvir 100mg/Sofosbuvir 400mg Tablets in bulk at competitive prices

Order Sovihep Velpatasvir 100mg/Sofosbuvir 400mg Tablets from our licensed international pharmacy. We provide genuine generic antiviral medicines in bulk to patients, doctors, hospitals, clinics, and healthcare professionals across multiple countries, including Colombia, Peru, the Philippines, Venezuela, Panama, Ecuador, Namibia, South Africa, Zimbabwe, Bahrain, Egypt, Cyprus, Iraq, Iran, Jordan, Israel, Qatar, Palestine, Saudi Arabia, the United Arab Emirates, Russia, Canada, Brazil, Mexico, China, Thailand, Singapore, Malaysia, Vietnam, South Korea, Taiwan, Indonesia, the United States, and more.